Sandoz awaiting facility inspections before filing Humira biosimilar in US
Capacity upgrades and US FDA discussions delayed the filing of Sandoz’ Humira biosimilar, the company has confirmed.
Archives for January 27, 2017
Lundbeck banks on shark antibody delivery tech to cross blood-brain barrier
Shark antibodies are an attractive way to deliver biologics to the brain, says Ossianix which is using its blood-brain barrier (BBB) crossing technology in collaboration with Lundbeck.
Trump's TPP withdrawal a boon for Asian biosimilar makers?
Trump, TPP and America First threaten US biomanufacturing jobs, says expert
Donald Trump’s withdrawal from the Trans-Pacific Partnership (TPP) could end up benefitting Asian biosimilar makers and reducing US jobs, says an IP lawyer.